Welcome   |  Our Faculty   |  Our Residents and Fellows   |   Neurology Residency Program   |   Fellowship Programs
Student Rotations  |   Conference Offerings   |   Research   |   Academic Website Links   |   Calendar For Current Residents
For Residents and Staff only   |

Faculty

Eric Eggenberger, D.O.Eric Eggenberger, D.O.
Professor and Vice-Chairman, Neurology

Academic Appointments

  • 2004-present: Professor and Vice Chairman, Michigan State University, Neurology
  • 2000-2004: Associate Professor and Vice Chairman, Michigan State University, Neurology
  • 1993-2000: Assistant Professor, Michigan State University, Physical Medicine and Rehabilitation (Neurology)

Postdoctoral Training

  • 2007: Epidemiology Masters Program
  • 1992-1993: Fellow in Neuro-Ophthalmology, Johns Hopkins Hospital
  • 1988-1992: Resident, Loyola University Medical Center, Neurology
  • 1987-1988: Intern, Detroit Osteopathic & Bi-County Community Hospital

Education

  • D.O., Michigan State University, 1987
  • B.S., Michigan State University, Nutritional Sciences, 1983

Education and Professional Positions

  • BS, Nutritional Science at Michigan State University, 1983
  • DO, Michigan State University College of Osteopathic medicine, 1987
  • Chief intern, Detroit Osteopathic & Bi-County Community Hospital 1987-88
  • Neurology resident, Loyola University Medical Center, Maywood, Illinois
  • Chief Resident, Neurology, Loyola University Medical Center, 1991-92
  • Fellow, Neuro-ophthalmology, Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore, Maryland
  • Assistant Professor, MSU, 1993
  • Associate Professor, Vice-Chairman, MSU Department of Neurology and Ophthalmology, 2000
  • Masters in Epidemiology, MSU, 1999-ongoing.
  • Clinical Interests and current position

Dr. Eggenberger’s clinical interests include neuro-ophthalmology, multiple sclerosis, and neuro-vestibular disorders. Neuro-ophthalmology interests include optic neuropathy, visual field deficits, diplopia/double vision, nystagmus, and vertigo. He is co-director of the Neuro-Visual Unit, and director of the MSU Ocular Motility Lab, Neuro-Vestibular Clinic and the MSU National Multiple Sclerosis Society (NMSS) Clinic.

Research Interests

  • Double vision, optic neuropathy and multiple sclerosis; optic neuropathy research has included the Ischemic Optic Neuropathy Decompression Trial (AION, or stroke of the optic nerve study), Longitudinal Optic Neuritis Study (optic neuritis – inflammation of the optic nerve study), and CHAMPS (Controlled High Risk MS Prevention Study – demonstrated the value of early MS treatment with interferon beta-1a).
  • Combi-Rx NIH funded Multiple Sclerosis Therapy Trial, 2005
  • CHAMPIONS (Controlled High risk AVONEX Multiple sclerosis Prevention study In On-going Neurologic Surveillance, C-850).
  • Controlled High Risk Patients, Avonex Multiple Sclerosis Prevention Study (CHAMPS): A randomized, double-blind, placebo-controlled study of Avonex (Interferon Beta 1a) in the treatment of subjects at high risk for development of multiple sclerosis following the first onset of an isolated demyelinating event. Biogen C95-812. Principal investigator and treating neurologist; April 1996.
  • Ischemic Optic Neuropathy Decompression Trial (IONDT), National Eye Institute, National Institutes of Health, June 1, 1992-November 30, 2000. Co-principal investigator.
  • Tamoxifen Ophthalmologic Evaluation Study (TOES). National Cancer Institute B14 Project Award (NIH), June 1, 1992-May 31, 1995. Co-principal investigator.
  • Longitudinal Optic Neuritis Study Grant. National Eye Institute, April 1, 1992 - March 31, 1997. Co-principal investigator

Selected Publications

Book Chapters

  • Eggenberger E, Cornblath W, eds. Neuro-ophthalmology. AAN Continuum. August 2009.
  • Eggenberger, Eric R.; Calvert, Preston C. NEUROMUSCULAR JUNCTION AND MECHANICAL CAUSES OF DIPLOPIA. SECTION 2 CONTINUUM: Lifelong Learning in Neurology. 15(4) Neuro-Ophthalmology:188-199, August 2009.
  • Eggenberger E. DIPLOPIA-HISTORY AND EXAMINATION. SECTION 2. AAN CONTINUUM: Lifelong Learning in Neurology. 15(4) Neuro-Ophthalmology:121-127, August 2009.
  • Eggenberger E. NYSTAGMUS AND OTHER ABNORMAL EYE MOVEMENTS. SECTION 2 AAN CONTINUUM: Lifelong Learning in Neurology. 15(4) Neuro-Ophthalmology:200-212, August 2009.
  • Optic disc edema with a macular star figure (neuroretinitis), In AG Lee, ed, Controversies in Neuro-ophthalmology. Informa Healthcare, 2009.
  • Intravenous (IV) steroids for giant cell arteritis, In AG Lee, ed, Controversies in Neuro-ophthalmology. Informa Healthcare, 2009.
  • Traumatic optic neuropathy treatment, In AG Lee, ed, Controversies in Neuro-ophthalmology. Informa Healthcare, 2009.
  • Rehabilitation therapy in homonymous hemianopsia; In AG Lee, ed, Controversies in Neuro-ophthalmology. Informa Healthcare, 2009.
  • Amiodarone related optic neuropathy, In AG Lee, ed, Controversies in Neuro-ophthalmology. Informa Healthcare, 2009.
  • Giant cell arteritis and fluorescein angiography. In AG Lee, ed, Controversies in Neuro-ophthalmology. Informa Healthcare, 2009.
  • Eggenberger E. Evaluation and management of optic neuritis. AG Lee, ed. Curbside Consultation in Neuro-ophthalmology. SLACK incorporated, Thorofare, NJ, 2009.
  • Prion Diseases. Eggenberger E. Chapter in, Neurologic Clinics of North America. Graff-Radford N, ed. August 2007.
  • Eggenberger E. The optic nerve and neuro-ophthalmology. Masters thesis; 2007.
  • Eggenberger ER. Nystagmus. In, ed. Arnold Anthony and Levin Lenard. Neuro-ophthalmology: The Essentials. Thieme Medical Publishers, New York, NY. 2005.
  • Kaufman DI, Eggenberger ER. Optic Nerve and chiasm. In, Celesia G, editor. Disorders of visual processing Elsevier 2005.
  • Eggenberger ER. Prions and Prion Diseases. In: Miller NR and Newman NJ, eds., Walsh and Hoyt’s Clinical Neuro-Ophthalmology, sixth edition. Williams and Wilkins, 2004.
  • Eggenberger ER. Emergency Neuro-Ophthalmology. In: Shah SM, Kelly KM, eds., Handbook of Emergency Neurology: Principles and Practice. Cambridge University Press New York, 2003.
  • Eggenberger ER, Rappley MD, Shah SM: Idiopathic Intracranial Hypertension. In: Shah SM, Kelly KM, eds., Emergency Neurology: Principles and Practice. Cambridge University Press New York, 1999.
  • Eggenberger ER, Hodge T: Neuro-ophthalmology. In: Shah SM, Kelly KM, eds., Emergency Neurology: Principles and Practice. Cambridge University Press New York, 1999.
  • Eggenberger ER. Prions and Prion Diseases. In: Miller NR and Newman NJ, eds., Walsh and Hoyt’s Clinical Neuro-Ophthalmology, fifth edition. Williams and Wilkins, 1997-1998.
  • Kaufman DI, Siebert JE, Pernicone JR, Eggenberger E: The Use of Magnetic Resonance Angiography in Neuro-Ophthalmology. In: Berman EL, Wirtschafter JD. eds. Imaging, Ophthalmology Clinics of North America. 1994; 7(3):487-508.
  • Eggenberger ER, Miller NR: Pseudotumor Cerebri. In: Hacke W, Hanley DF, Einhaupl K, Bleck TB, Diringer M, eds., Neurocritical Care, Springer-Verlag, Inc., NY, Inc., New York, NY, 1994.

Papers

  • Eggenberger ER. Anisocoria. eMedicine from WebMD. Updated May 06, 2010. Available at: http://emedicine.medscape.com/article/1158571-overview.
  • Younis A, Eggenberger E. Correlation between relative afferent pupillary defect and retinal nerve fiber layer loss in unilateral or asymmetric demyelinating optic neuropathy. Investigative Ophthalmology & Visual Science 2010;51:4013-4016.
  • Geddie BE, Altiparmak UE, Eggenberger ER. The Cup-to-Disc Ratio in Patients With Idiopathic Intracranial Hypertension Is Smaller Than In Normal Subjects. J Neuro-ophthalmology 2010.
  • Murad-Kejbou S, Eggenberger E. Pituitary apoplexy: evaluation, management, and prognosis. Current Opinion in Ophthalmology. November 2009 - Volume 20 - Issue 6 - p 456-461
  • Subei AM, Eggenberger E. OCT: Another Useful Tool in a Neuro-Ophthalmologist’s Armamentarium. Current Opinion in Ophthalmology. November 2009 Vol 20 Issue 6
  • Williams Z, Hurley P, Altiparmak U, Feldon S, Arnold G, Eggenberger E, Mejico L. Late Onset Optic Neuropathy in Methylmalonic and Propionic Acidemia. American Journal of Ophthalmology, 2009 Volume 147, Issue 5, Pages 929-933
  • AR Salter, A Conger, TC Frohman, R Zivadinov, E Eggenberger, P Calabresi, G Cutter, L Balcer, EM Frohman. Retinal architecture predicts pupillary reflex metrics in MS. Multiple Sclerosis. 2009 Apr;15(4):479-86. Epub 2008 Dec 17.
  • Pula JH, Eggenberger E. Posterior reversible encephalopathy syndrome. Current Opinion in Ophthalmology 2008,19:479–484
  • Antonio-Santos AA, Eggenberger ER. Medical treatment options for ocular myasthenia gravis. Current Opinion in Ophthalmology 2008,19:468–478
  • Break in binocular fusion during head turning in MS patients with INO. D.A. Mills, T.C. Frohman, S.L. Davis, A.R. Salter, S. McClure, I. Beatty, A. Shah, S. Galetta, E. Eggenberger, D.S. Zee, and E.M. Frohman. Neurology 2008;71(6):458
  • LONS Study Group. Multiple Sclerosis Risk after Optic Neuritis: Final Optic Neuritis Treatment Trial Follow Up. Arch Neurology 2008; 65:727-732.
  • Costello F, Hodge W, Pan YI, Eggenberger E, Coupland S, Kardon RH. Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography. Mult Scler. 2008 Aug;14(7):893-905. Epub 2008 Jun 23
  • Winterkorn JM, Mack P, Eggenberger E. Transient visual loss in a 60-year-old man. Surv Ophthalmol. 2008 May-Jun;53(3):301-5.
  • Demidenko; Vakili; Eggenberger; Kaufman. Late onset Leber’s Hereditary Optic Neuropathy. Neuro-Ophthalmology 2/08.
  • Rudick RR, Miller D, Hass S, et al (and AFFIRM and SENTINEL Investigators). Health-related quality of life in multiple sclerosis: effects of natalizumab Annals of Neurology 2007;62(4): 335 – 346.
  • LONS Study Group. Optic Neuritis Study Group. Visual Function 15 Years after Optic Neuritis: A Final Follow-up Report from the Optic Neuritis Treatment Trial. Ophthalmology; 2008;115:1079-1082.
  • I. Corticosteroids and ACTH for Multiple Sclerosis: Application for Treating MS Exacerbations. Frohman EM, Shah A, Eggenberger E, Zivadinov R, Stüve O. October 2007 Neurotherapeutics.
  • II. Corticosteroids and ACTH for Multiple Sclerosis: Application For Disease Modifying Effects. Frohman EM, Shah A, Eggenberger E, Zivadinov R, Stüve O. October 2007 Neurotherapeutics.
  • Miller NR, Cornblath WT, Lee AG, Eggenberger E, Savino PJ, Golnik KC. Giant Cell Arteritis. Reply. Ophthalmology 2007; 114:1235-1236.
  • Asaccadia and Ataxia after Repair of Ascending Aortic Aneurysm. Aileen Antonio-Santos, M.D. and Eric R. Eggenberger, D.O. Seminars in Ophthalmology, Volume 22 Issue 1 2007.
  • The Ratio of Square Wave Jerks to Blink Rates Distinguishes Progressive Supranuclear Palsy from Parkinson Disease. Ugur E. Altiparmak, MD, Eric Eggenberger, DO, Austin Coleman, DO, Kelly Condon. J Neuroophthalmol. 2006 Dec;26(4):257-9.
  • Vakili R. A Majid, and E. Eggenberger. Early detection of Heidenhain Variant Creutzfeldt-Jakob disease with Diffusion-weighted Magnetic Resonance Imaging. Annals of Neurology. Volume 60, Issue S10, page S69. Oct. 2006.
  • Glisson C, Eggenberger E, Miller N. Supranuclear Ophthalmoplegia as a Complication of Coronary Angiography. Neuro-Ophthalmology, Volume 30, Number 4, July-August 2006, pp. 101-103(3).
  • Cherian V, Eggenberger E. Levetiracetam effect in demyelinating ocular flutter with myoclonus. Neuro-Ophthalmology, Volume 30, Number 4, July-August 2006, pp. 105-108(4)
  • IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Kinkel RP, Kollman C, O'Connor P; Murray TJ; Simon J; Arnold D; Bakshi R; Weinstock-Gutman B; Brod S; Cooper J; Duquette P; Eggenberger E; Felton W; Fox R; Freedman M; Galetta S; Goodman A; Guarnaccia J; Hashimoto S; Horowitz S; Javerbaum J; Kasper L; Kaufman M; Kerson L; Mass M; Rammohan K; Reiss M; Rolak L; Rose J; Scott T; Selhorst J; Shin R; Smith C; Stuart W; Thurston S; Wall M. Neurology. 2006 Mar 14; 66(5): 678-84
  • Eggenberger ER, Lee AG, Lai E. Neuro-ophthalmic findings in patients with the anti-GAD antibody syndrome. Neuro-Ophthalmology, 2006;30:1-6.
  • Antonio A, Santos R, Eggenberger E. Pharmacologic testing of anisocoria. Expert Opinion Pharmacotherapy 2005.
  • Kaufman DI, Eggenberger ER, editors. Ophthalmology Clinics of North America. Neuro-ophthalmology of systemic Disease. Fall 2004.
  • American Academy of Ophthalmology Basic and Clinical Science Course. Section 5 Neuro-Ophthalmology 2004, section editor (Chair Lanning Kline, MD)
  • Eggenberger ER. Inflammatory Optic Neuropathies. Ophthalmology Clinics of North America, March 2001
  • Eggenberger ER, Cornblath W, Stewart DH. Oculopalatal Tremor and Pendular Nystagmus with Progressive Ataxia, J Neuro-Ophthalmology, 2001.
  • Jacobs LD, Beck RW, Simon JH et al (CHAMPS Study Group). Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 2000;343:898-904.
  • Eggenberger ER, Desai NP, Kaufman DI, Pless, M. Internuclear Ophthalmoplegia After Coronary Artery Catheterization and Percutaneous Transluminal Coronary Balloon Angioplasty. Journal of Neuro-Ophthalmology, 20(2): 123-126, 2000.
  • Eggenberger ER, Kaufman DI. Ocular Motility Review for 1997-1998: Part II. Journal of Neuro-Ophthalmology, 20(3): 192-206, 2000.
  • Eggenberger ER, Kaufman DI. Ocular Motility Review for 1997-1998: Part I. Journal of Neuro-Ophthalmology, 20(2): 73-84, 2000.
  • Kaufman DI, Trobe JD, Eggenberger ER, Whitaker JN. Practice Parameters: The Role of Corticosteroids in the Management of Acute Monosymptomatic Optic Neuritis. Neurology, 2000; 54: 2039-2044.
  • Brazis PW, Lee AG, Graff-Radford N, Desai NP, Eggenberger ER. Homonymous Visual Field Defects in Patients Without Corresponding Structural Lesions on Neuroimaging. Journal of Neuro-Ophthalmology, 20(2): 92-96, 2000.
  • Eggenberger ER. Letter: BRVO in Bartonella henselae: Posterior Segment Manifestations article. Ophthalmology, 107(5): 817-818, May 2000.
  • Jacobson D, Eggenberger E, Liu, Galetta S, Moster, ML. Isolated Trochlear Nerve Palsy in Patients With Multiple Sclerosis. Neurology, 53: 877-879, 1999.
  • Eggenberger ER. Ocular Neuromyotonia: Report of 2 cases, review of the Literature and Pathophysiologic Hypothesis. Neuro-Ophthalmology, 21:249-254, 1999.
  • Lee AG, Eggenberger ER, Kaufman DI, Manrique C. Optic Nerve Enhancements on Magnetic Resonance Imaging in Arteritic Ischemic Optic Neuropathy. Journal of Neuro-Ophthalmology, 19(4): 235-237, 1999.
  • Golnik KC, Pena R, Lee AG, Eggenberger ER. An Ice Test for the Diagnosis of Myasthenia Gravis. Ophthalmology, 1999; 106:1282-1286.
  • Ischemic Optic Neuropathy Decompression Study Group. The Ischemic Optic Neuropathy Decompression Trial (IONDT): Design and Methods. Controlled Clinical Trials, 1998, 19:276-296.
  • Miller RW, Lee AG, Schiffman JS, Prager TC, Garza R, Jenkins PF, Sforza P, Verm A, Kaufman DI, Robinson W, Eggenberger ER, Tang RA. A Practice Pathway for the Initial Diagnostic Evaluation of Isolated Sixth Cranial Nerve Palsies. Medical Decision Making, 1998 Jan-Mar; 19:42-48.
  • Fierz A, Eggenberger ER. The European Carotid Surgery Trial (ECST) and Retinal TIA - Correspondence. The Lancet, 1998;352:144.
  • Eggenberger ER, Kaufman DI. Ocular Motility Review for 1996. Journal of Neuro-Ophthalmology, 18 (3): 211-226, 1998.
  • Chiu AM, Chuenkongkaew WL, Cornblath WT, Trobe JD, Digre KB, Dotan SA, Musson KH, Eggenberger ER. Minocycline and Pseudotumor Cerebri Syndrome. American Journal of Ophthalmology, 1998; 126:116-121.
  • Vaphiades M., Eggenberger ER. Childhood Sarcoid. Journal of Neuro-Ophthalmology, 1998; 18(2):99-101.
  • Desai N, Kaufman DI, Eggenberger ER. Prognosis of Visual Field Defects in Stroke. Ophthalmology Surgery, 1998.
  • Eggenberger ER. Eight and a Half Syndrome: One and a Half Syndrome Plus Cranial Nerve VII Palsy. Journal of Neuro-Ophthalmology, 1998; 18(2):114-116.
  • Vaphiades M, Eggenberger ER. The Pulfrich Effect and its Relationship to Retinal Illumination. Journal of Neuro-Ophthalmology, 1997 Dec; 17(4):240-2.
  • The LONS Study Group. Visual Function Five Years After Optic Neuritis: Experience of the Optic Neuritis Treatment Trial. Archives of Ophthalmology, 1997 Dec; 115(12):1545-52.
  • The LONS Study Group. The Five-Year Risk of Multiple Sclerosis After Optic Neuritis: Experience of the Optic Neuritis Treatment Trial. Neurology, 1997; 49:1404-1413.
  • Cornblath WT, Eggenberger ER. Progressive Visual Loss from Giant Cell Arteritis despite High-dose Intravenous Methylprednisolone. Ophthalmology, 1997 May; 104(5):854-858.
  • Eggenberger ER: Neuro-Ophthalmology of Multiple Sclerosis. Current Opinion in Ophthalmology, 1996; 7 (6):19-29.
  • The IONDT Research Group. Characteristic of Patients with Nonarteritic Anterior Ischemic Optic Neuropathy Eligible for the Ischemic Optic Neuropathy Decompression Trial. Archives of Ophthalmology 1996 Nov; 114: 1366-1374.
  • Eggenberger ER, Miller NR. Lumboperitoneal Shunting for Pseudotumor Cerebri. Neurology. 1996 June; 46 ( 6): 1524-1529.
  • The IONDT Research Group. Optic nerve Sheath Decompression Surgery for Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) is Not Effective and May be Harmful. The Journal of the American Medical Association. 1995; 275:625-632.
   
Email Address:

Copyright © 2006 Michigan State University. All Rights Reserved. Site designed by Academic Web Pages.